Covid-19: New data on Oxford AstraZeneca vaccine backs 12 week dosing interval

被引：25

|

作者：

Wise, Jacqui

机构：

来源：

BMJ-BRITISH MEDICAL JOURNAL | 2021年 / 372卷

关键词：

D O I：

10.1136/bmj.n326

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页数：1

相关论文

共 50 条

[21] De novo generalized pustular psoriasis following Oxford-AstraZeneca COVID-19 vaccine
Elamin, S.
Hinds, F.
Tolland, J.
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2022, 47 (01) : 153 - 155
[22] Oxford-AstraZeneca COVID-19 vaccine-induced acute localized exanthematous pustulosis
Wu, Ro-Wei
Lin, Tzu-Kai
JOURNAL OF DERMATOLOGY, 2021, 48 (11): : E562 - E563
[23] COVID-19 New problems erode confidence in AstraZeneca's vaccine
Vogel, Gretchen
Kupferschmidt, Kai
SCIENCE, 2021, 371 (6536) : 1294 - 1295
[24] Acute rejection following COVID-19 vaccine (AstraZeneca)
Varma, Prem P.
Kute, Vivek B.
Kumar, Prateek
INDIAN JOURNAL OF TRANSPLANTATION, 2022, 16 (04) : 465 - 466
[25] Canadian findings on AstraZeneca COVID-19 Vaccine and COVISHIELD
Reactions Weekly, 2021, 1853 (1) : 1 - 1
[26] TTS rare after AstraZeneca COVID-19 vaccine
Reactions Weekly, 2022, 1923 (1) : 12 - 12
[27] Bullous pemphigoid induced by the AstraZeneca COVID-19 vaccine
Agharbi, F. -Z
Eljazouly, M.
Basri, G.
Faik, M.
Benkirane, A.
Albouzidi, A.
Chiheb, S.
ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2022, 149 (01): : 56 - 57
[28] Bleeding and clotting with AstraZeneca's COVID-19 vaccine
Reactions Weekly, 2021, 1857 (1) : 1 - 1
[29] No increased risk of anaphylaxis with AstraZeneca COVID-19 vaccine
Reactions Weekly, 2021, 1849 (1) : 3 - 3
[30] Anaphylaxis in Australia with AstraZeneca's COVID-19 vaccine
Reactions Weekly, 2021, 1848 (1) : 1 - 1

← 1 2 3 4 5 →